Sveriges mest populära poddar
The Long Run with Luke Timmerman
Vetenskap

Ep191: Emily Conley on Small Molecules to Correct a Rare Kidney Disease

1 tim 8 min•15 december 2025
Emily Conley, CEO of Berkeley, CA-based Renasant Bio, on developing small molecule correctors and potentiators for autosomal dominant polycystic kidney disease (ADPKD).

Fler avsnitt av The Long Run with Luke Timmerman

Visa alla avsnitt av The Long Run with Luke Timmerman
Ep196: Otello Stampacchia on Europe's Biotech Crisis
•1 tim 3 min
Ep195: Ken Song on T-cell Engagers for Autoimmune Diseases
•1 tim 6 min
Ep194: Ansu Satpathy on Cancer and Autoimmune Drug Discovery
•1 tim 9 min
Ep193: Ron Renaud on Helping People Lose Weight With GLP-1 Medicines
•1 tim 5 min
Ep192: Kate Haviland on Following the Science to Precision Immunology
•1 tim 26 min
Ep190: Neil Kumar on Building a Rare Disease Drug Company
•1 tim 13 min
Ep189: Marc Tessier-Lavigne on Reinventing Drug Discovery with AI
•1 tim 13 min
Ep188: Art Krieg on Innate Immune System Activators for Cancer
•1 tim 9 min
Ep187: Eric Fischer on Creating a New Class of Medicines
•1 tim 6 min
Ep186: Bruce Levine & Mags McCarthy on a Song About Science and Hope
•1 tim 3 min

The Long Run with Luke Timmerman med Timmerman Report finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.